Biotech 20lab

Network Immunology Inc.

Entirely novel immune system modification technology platform for transplantation. We have early interest from Pharma for the transplantation technology.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Vancouver, BC, Canada
  • Currency CAD
  • Founded June 2003
  • Employees 12
  • Website

Company Summary

Network Immunology is developing a platform technology for immune system modification.

The technology's indications include degenerative diseases and transplantation.

We plan to be acquired by a large Biotech or Pharma company.

At this stage there is initial interest for our technology from one large Pharma company.


  • Default avatar
    George Hoffmann
    President and CEO

  • Default avatar
    Geoffrey Hoffmann
    Chairman and Chief Scientist

  • Default avatar
    Jonathan Willmer


Previous Investors